SL
AZN icon

Savior LLC’s AstraZeneca AZN Stock Holding History

Savior LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15
Closed -$2K – 232
2021
Q2 		$2K Hold
15
– – ﹤0.01% 707
2021
Q1 		$1K Hold
15
– – ﹤0.01% 800
2020
Q4 		$1K Hold
15
– – ﹤0.01% 767
2020
Q3 		$2K Hold
15
– – ﹤0.01% 662
2020
Q2 		$2K Sell
15
-107
-88% -$11.1K ﹤0.01% 620
2020
Q1 		$11K Sell
122
-14
-10% -$1.32K 0.01% 299
2019
Q4 		$14K Buy
+136
New +$12.8K 0.02% 364

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Savior LLC's AZN Position: Q3 2021 in Review

Savior LLC sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 15 shares — an estimated $2K sold.

Savior LLC first reported a position in AZN in Q4 2019 and held it in 7 quarters. The position peaked at $14K in Q4 2019. 908 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

  • Savior LLC reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 15 AstraZeneca shares in Q3 2021, an estimated $2K.
  • Savior LLC first reported a position in AstraZeneca in Q4 2019 and held it in 7 quarters.
  • Savior LLC's AstraZeneca position peaked at $14K in Q4 2019.
  • 908 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.